ClinicalTrials.govpublic full text
Bevacizumab Combined With Cisplatin Versus Cisplatin Monotherapy in Malignant Serous Effusions
overall response rate, bevacizumab, malignant serous effusions, randomized study, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 870019
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.